These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7922132)

  • 21. Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands.
    De Amici M; Conti P; Fasoli E; Barocelli E; Ballabeni V; Bertoni S; Impicciatore M; Roth BL; Ernsberger P; De Micheli C
    Farmaco; 2003 Sep; 58(9):739-48. PubMed ID: 13679167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocytosis and recycling of muscarinic receptors.
    Edwardson JM; Szekeres PG
    Life Sci; 1999; 64(6-7):487-94. PubMed ID: 10069514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
    Lee SY; Zhu SZ; el-Fakahany EE
    Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors.
    Michal P; Lysíková M; El-Fakahany EE; Tucek S
    Eur J Pharmacol; 1999 Jul; 376(1-2):119-25. PubMed ID: 10440097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentatomic cyclic agonists and muscarinic receptors: a 20 years review.
    Angeli P
    Farmaco; 1995 Sep; 50(9):565-77. PubMed ID: 7495467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
    Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
    Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of an ectopic activation site on the M(1) muscarinic receptor.
    Spalding TA; Trotter C; Skjaerbaek N; Messier TL; Currier EA; Burstein ES; Li D; Hacksell U; Brann MR
    Mol Pharmacol; 2002 Jun; 61(6):1297-302. PubMed ID: 12021390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite: demox, a modulator of orthosteric and allosteric sites at cardiac muscarinic M2 receptors.
    Angeli P; Marucci G; Buccioni M; Piergentili A; Giannella M; Quaglia W; Pigini M; Cantalamessa F; Nasuti C; Novi F; Maggio R; Qasem AR; Spampinato S
    Life Sci; 2002 Feb; 70(12):1427-46. PubMed ID: 11883718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic receptor ligands and their therapeutic potential.
    Eglen RM; Choppin A; Dillon MP; Hegde S
    Curr Opin Chem Biol; 1999 Aug; 3(4):426-32. PubMed ID: 10419852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of ligand-receptor binding thermodynamics by free energy force field three-dimensional quantitative structure-activity relationship analysis: applications to a set of glucose analogue inhibitors of glycogen phosphorylase.
    Venkatarangan P; Hopfinger AJ
    J Med Chem; 1999 Jun; 42(12):2169-79. PubMed ID: 10377222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the role of an amino acid triplet repeat in differentiating drug-receptor interaction at m1 and m2 muscarinic receptors.
    Zhu SZ; Lee SY; Wang SZ; el-Fakahany EE
    Pharmacology; 1995 Nov; 51(5):298-307. PubMed ID: 8584581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3.
    Selent J; Brandt W; Pamperin D; Göber B
    Bioorg Med Chem; 2006 Mar; 14(6):1729-36. PubMed ID: 16290166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
    Shim JY; Welsh WJ; Howlett AC
    Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological characterization of bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective muscarinic agonists.
    Rajeswaran WG; Cao Y; Huang XP; Wroblewski ME; Colclough T; Lee S; Liu F; Nagy PI; Ellis J; Levine BA; Nocka KH; Messer WS
    J Med Chem; 2001 Dec; 44(26):4563-76. PubMed ID: 11741475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic receptor subtypes and the selectivity of agonists and antagonists.
    Birdsall NJ; Curtis CA; Eveleigh P; Hulme EC; Pedder EK; Poyner D; Wheatley M
    Pharmacology; 1988; 37 Suppl 1():22-31. PubMed ID: 2467316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In primary neuronal cultures muscarinic m1 and m3 receptor mRNA levels are regulated by agonists, partial agonists and antagonists.
    Brusa R; Gamalero SR; Genazzani E; Eva C
    Eur J Pharmacol; 1995 Mar; 289(1):9-16. PubMed ID: 7781716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the muscarinic receptor subtypes in the bovine corneal epithelial cells.
    Socci RR; Tachado SD; Aronstam RS; Reinach PS
    J Ocul Pharmacol Ther; 1996; 12(3):259-69. PubMed ID: 8875332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bitopic muscarinic agonists and antagonists and uses thereof: a patent evaluation of US20160136145A1.
    Holzgrabe U; Decker M
    Expert Opin Ther Pat; 2017 Feb; 27(2):121-125. PubMed ID: 27967250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis.
    Page KM; Curtis CA; Jones PG; Hulme EC
    Eur J Pharmacol; 1995 May; 289(3):429-37. PubMed ID: 7556411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.